Trial
NCT05991622
Combined Injectable Treatment for HIV and OUD
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Rhode Island Hospital
Collaborators
—
Condition
Human Immunodeficiency Virus
Intervention
Combined LAI Treatment: Cabenuva and Sublocade
Why stopped
The study was initiated but no participants were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-18